vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and REGIS CORP (RGS). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). REGIS CORP runs the higher net margin — 0.8% vs -19.9%, a 20.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 22.3%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 7.8%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
ABCL vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $57.1M |
| Net Profit | $-8.9M | $456.0K |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 10.8% |
| Net Margin | -19.9% | 0.8% |
| Revenue YoY | 788.4% | 22.3% |
| Net Profit YoY | 73.9% | -94.0% |
| EPS (diluted) | $-0.03 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $57.1M | ||
| Q3 25 | $9.0M | $59.0M | ||
| Q2 25 | $17.1M | $60.4M | ||
| Q1 25 | $4.2M | $57.0M | ||
| Q4 24 | $5.0M | $46.7M | ||
| Q3 24 | $6.5M | $46.1M | ||
| Q2 24 | $7.3M | $49.4M | ||
| Q1 24 | $10.0M | $49.2M |
| Q4 25 | $-8.9M | $456.0K | ||
| Q3 25 | $-57.1M | $1.4M | ||
| Q2 25 | $-34.7M | $116.5M | ||
| Q1 25 | $-45.6M | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-51.1M | $-853.0K | ||
| Q2 24 | $-36.9M | $91.2M | ||
| Q1 24 | $-40.6M | $-2.3M |
| Q4 25 | -63.7% | 10.8% | ||
| Q3 25 | -851.8% | 10.0% | ||
| Q2 25 | -290.2% | 12.1% | ||
| Q1 25 | -1479.6% | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -1439.4% | 4.6% | ||
| Q2 24 | -1276.2% | — | ||
| Q1 24 | -551.5% | 8.3% |
| Q4 25 | -19.9% | 0.8% | ||
| Q3 25 | -637.8% | 2.3% | ||
| Q2 25 | -203.3% | 192.9% | ||
| Q1 25 | -1077.2% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | -785.4% | -1.9% | ||
| Q2 24 | -504.3% | 184.7% | ||
| Q1 24 | -408.0% | -4.7% |
| Q4 25 | $-0.03 | $0.16 | ||
| Q3 25 | $-0.19 | $0.49 | ||
| Q2 25 | $-0.12 | $43.67 | ||
| Q1 25 | $-0.15 | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | $-0.17 | $-0.36 | ||
| Q2 24 | $-0.13 | $38.40 | ||
| Q1 24 | $-0.14 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $966.9M | $188.7M |
| Total Assets | $1.4B | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $18.4M | ||
| Q3 25 | $83.2M | $16.6M | ||
| Q2 25 | $92.4M | $17.0M | ||
| Q1 25 | $159.3M | $13.3M | ||
| Q4 24 | $156.3M | $10.2M | ||
| Q3 24 | $126.6M | $6.3M | ||
| Q2 24 | $148.3M | $10.1M | ||
| Q1 24 | $123.6M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $966.9M | $188.7M | ||
| Q3 25 | $964.0M | $187.6M | ||
| Q2 25 | $1.0B | $185.6M | ||
| Q1 25 | $1.0B | $68.6M | ||
| Q4 24 | $1.1B | $66.7M | ||
| Q3 24 | $1.1B | $56.4M | ||
| Q2 24 | $1.1B | $56.8M | ||
| Q1 24 | $1.1B | $-35.8M |
| Q4 25 | $1.4B | $588.3M | ||
| Q3 25 | $1.4B | $592.1M | ||
| Q2 25 | $1.4B | $599.0M | ||
| Q1 25 | $1.3B | $511.2M | ||
| Q4 24 | $1.4B | $530.1M | ||
| Q3 24 | $1.4B | $508.9M | ||
| Q2 24 | $1.4B | $530.5M | ||
| Q1 24 | $1.5B | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $1.7M |
| Free Cash FlowOCF − Capex | $-44.6M | $891.0K |
| FCF MarginFCF / Revenue | -99.4% | 1.6% |
| Capex IntensityCapex / Revenue | 21.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $1.7M | ||
| Q3 25 | $-52.6M | $2.3M | ||
| Q2 25 | $-32.4M | $6.8M | ||
| Q1 25 | $-11.6M | $6.2M | ||
| Q4 24 | $-108.6M | $2.1M | ||
| Q3 24 | $-28.9M | $-1.3M | ||
| Q2 24 | $-30.0M | $5.1M | ||
| Q1 24 | $-41.7M | $-277.0K |
| Q4 25 | $-44.6M | $891.0K | ||
| Q3 25 | $-61.5M | $1.9M | ||
| Q2 25 | $-45.8M | $6.2M | ||
| Q1 25 | $-22.2M | $5.9M | ||
| Q4 24 | $-187.0M | $1.7M | ||
| Q3 24 | $-47.4M | $-1.4M | ||
| Q2 24 | $-50.1M | $5.1M | ||
| Q1 24 | $-65.8M | $-326.0K |
| Q4 25 | -99.4% | 1.6% | ||
| Q3 25 | -687.0% | 3.2% | ||
| Q2 25 | -267.9% | 10.3% | ||
| Q1 25 | -524.0% | 10.3% | ||
| Q4 24 | -3702.8% | 3.6% | ||
| Q3 24 | -728.4% | -3.0% | ||
| Q2 24 | -683.8% | 10.3% | ||
| Q1 24 | -661.5% | -0.7% |
| Q4 25 | 21.9% | 1.4% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 0.9% | ||
| Q1 25 | 251.1% | 0.6% | ||
| Q4 24 | 1552.7% | 0.9% | ||
| Q3 24 | 284.6% | 0.0% | ||
| Q2 24 | 274.6% | 0.0% | ||
| Q1 24 | 242.5% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
